Best Telehealth Clinics in Michigan (2026)

Michigan has one of the most permissive telehealth prescribing frameworks in the country. MCL 333.16285 (Michigan Public Health Code, Act 368 of 1978, as amended) permanently authorizes telehealth prescribing including controlled substances without a mandatory in-person visit. Unlike most states, Michigan did not rely on COVID emergency declarations for its telehealth framework. The Public Health Code was amended directly to make telehealth permanent.

Public Acts 51-53 of 2024 (HB 4131, 4213, 4579, 4580) further solidified the framework by establishing payment parity for telehealth services and protections for telemedicine access through Medicaid and state-regulated insurance. This legislation ensures that insurers cannot reimburse telehealth at a lower rate than in-person visits.

MCL 333.16285 permits health professionals providing telehealth services to prescribe controlled substances without a prior in-person examination, provided they meet all Public Health Code requirements for prescribing that substance. This means testosterone (Schedule III) can be prescribed via telehealth without any in-person visit under state law alone, not just under the federal DEA waiver. Michigan is more permissive than states like Ohio, Illinois, and Pennsylvania on this point.

After prescribing via telehealth, the health professional must make themselves available for follow-up care or refer the patient to another provider. Michigan has its own PDMP called MAPS (Michigan Automated Prescription System). Prescribers must check MAPS before issuing controlled substance prescriptions.

Michigan's IMLC status is complicated. Michigan was an IMLC member but repealed its participation statute on March 28, 2025, beginning a 12-month withdrawal process. Michigan Senate Bill 303 (2025) passed the Senate unanimously on May 21, 2025 and was in the House Health Policy Committee as of June 2025. If passed, it would restore IMLC membership. As of April 2026, Michigan's IMLC status is uncertain. Physicians should verify current compact status before relying on IMLC for Michigan licensure.

Michigan has 10.1 million residents and is the tenth-largest state. Provider availability is strong thanks to the permissive telehealth framework. Of the 64 providers tracked on ClinicLayer, roughly 55 serve Michigan. The uncertain IMLC status may slow new provider entry, but most established providers already hold Michigan licenses.

All major TRT providers serve Michigan. Maximus ($100/mo with labs, all 50 states), Hone Health ($25/mo entry, all 50 states), TRT Nation ($99/mo, serves 45 states including MI), BraverX ($129/mo with labs), PeterMD ($99/mo annual with labs), DudeMeds ($77/mo), and Titan Medical ($99/mo) are available. Defy Medical ($200/mo) and Marek Health ($166/mo) serve "Most US states" and include Michigan.

GLP-1 availability is unrestricted at the state level. Embody ($99/mo), SkinnyRx ($99/mo), DirectMeds ($199/mo), Zealthy ($99/mo), Remedy Meds ($179/mo), GobyMeds ($119/mo), Sesame Care, Shed ($199/mo), MEDVi ($179/mo), Sunlight ($179/mo), Fridays ($117/mo), and Mochi Health ($99/mo) all serve the state. CareBare and Novi serve "Most US states."

All HRT providers are available in Michigan. Midi Health accepts insurance. PlushCare ($20/mo) accepts major insurers. All hair loss and ED providers serve the state. Enhance MD does not appear to exclude Michigan from its 38 served states.

Feel30 may or may not serve Michigan for TRT. Their exclusion list includes 16 states. Patients should verify directly. The enclomiphene service covers all 50 states.

TRT pricing in Michigan matches national rates. DudeMeds: $77/mo (labs $200 extra, $1,124/year). TRT Nation: $99/mo (labs $258 extra, $1,446/year). PeterMD: $99/mo annual (labs included, $1,188/year). Maximus: $100/mo annual (labs included, $1,300/year). Titan Medical: $99/mo (labs $229 extra, $1,417/year). BraverX: $129/mo (labs included, $1,548/year). Defy Medical: $200/mo ($2,800/year). The cheapest all-in option is PeterMD at $1,188/year with upfront annual payment.

GLP-1 starts at $99/mo and goes up to $399/mo. GobyMeds at $119/mo and Fridays at $117/mo are budget options for compounded semaglutide. The median across providers is $179/mo.

Michigan Medicaid has restricted GLP-1 weight-loss coverage. Effective January 1, 2026, Michigan Medicaid limited GLP-1 weight-loss coverage (Wegovy, Zepbound, Saxenda) to patients with BMI of 40 or higher (morbid obesity) only. Prior authorization is required, and patients must have documented failure of other weight-loss interventions. The restriction is projected to save $240 million. GLP-1s for type 2 diabetes (Ozempic, Mounjaro) remain fully covered. Previously, Michigan covered GLP-1s more broadly for weight loss, making this a significant pullback.

Michigan does not tax prescription medications. The state sales tax is 6% but does not apply to Rx drugs. Telehealth consultations are not separately taxed.

HRT: Midi Health (insurance), PlushCare ($20/mo), Evernow ($35/mo), Alloy ($49/mo). ED: Hims $17/mo to MEDVi $119/mo. Hair loss: Hims $20/mo to Nutrafol $88/mo.

TRT (testosterone replacement therapy)

Michigan is one of the most permissive states for telehealth TRT. MCL 333.16285 explicitly allows controlled substance prescribing via telehealth without a prior in-person visit under state law. This is not dependent on the federal DEA waiver. Testosterone (Schedule III) is freely prescribable via telehealth. MAPS (the state PDMP) must be checked. Both compounded and FDA-approved testosterone are available. Delivery methods include injection, cream, oral, and enclomiphene.

GLP-1 weight loss

No state-specific restrictions on semaglutide or tirzepatide in Michigan. Federal FDA compounding rules apply. Michigan Board of Pharmacy has not issued separate state-level compounding guidance comparable to Ohio's July 2025 FAQ. Michigan Medicaid covers weight-loss GLP-1s only for BMI 40+ as of January 2026.

HRT (hormone replacement therapy)

HRT follows standard federal prescribing rules in Michigan. No additional state restrictions apply. All HRT providers serve the state. Midi Health accepts insurance.

Hair loss

Hair loss treatment follows standard federal prescribing rules in Michigan. No additional state restrictions apply.

ED (erectile dysfunction)

ED treatment follows standard federal prescribing rules in Michigan. No additional state restrictions apply.

Peptides

Peptide therapy follows standard federal rules in Michigan. Michigan's permissive telehealth statute (MCL 333.16285) applies to peptide prescribing as well. Sermorelin, BPC-157, and NAD+ are available from Maximus and Defy Medical. No state-specific peptide restrictions were identified.